These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22279083)

  • 1. An enhancer from the 8q24 prostate cancer risk region is sufficient to direct reporter gene expression to a subset of prostate stem-like epithelial cells in transgenic mice.
    Ting MC; Liao CP; Yan C; Jia L; Groshen S; Frenkel B; Roy-Burman P; Coetzee GA; Maxson R
    Dis Model Mech; 2012 May; 5(3):366-74. PubMed ID: 22279083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer.
    Wasserman NF; Aneas I; Nobrega MA
    Genome Res; 2010 Sep; 20(9):1191-7. PubMed ID: 20627891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of the
    Xie Q; Wang ZA
    J Biol Chem; 2017 Aug; 292(33):13521-13530. PubMed ID: 28679531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling.
    Tuupanen S; Turunen M; Lehtonen R; Hallikas O; Vanharanta S; Kivioja T; Björklund M; Wei G; Yan J; Niittymäki I; Mecklin JP; Järvinen H; Ristimäki A; Di-Bernardo M; East P; Carvajal-Carmona L; Houlston RS; Tomlinson I; Palin K; Ukkonen E; Karhu A; Taipale J; Aaltonen LA
    Nat Genet; 2009 Aug; 41(8):885-90. PubMed ID: 19561604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Networks of intergenic long-range enhancers and snpRNAs drive castration-resistant phenotype of prostate cancer and contribute to pathogenesis of multiple common human disorders.
    Glinskii AB; Ma S; Ma J; Grant D; Lim CU; Guest I; Sell S; Buttyan R; Glinsky GV
    Cell Cycle; 2011 Oct; 10(20):3571-97. PubMed ID: 22067658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A luminal epithelial stem cell that is a cell of origin for prostate cancer.
    Wang X; Kruithof-de Julio M; Economides KD; Walker D; Yu H; Halili MV; Hu YP; Price SM; Abate-Shen C; Shen MM
    Nature; 2009 Sep; 461(7263):495-500. PubMed ID: 19741607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct regulatory elements mediate the dynamic expression pattern of Nkx3.1.
    Chen H; Mutton LN; Prins GS; Bieberich CJ
    Dev Dyn; 2005 Dec; 234(4):961-73. PubMed ID: 16245334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function.
    Zheng SL; Ju JH; Chang BL; Ortner E; Sun J; Isaacs SD; Sun J; Wiley KE; Liu W; Zemedkun M; Walsh PC; Ferretti J; Gruschus J; Isaacs WB; Gelmann EP; Xu J
    Cancer Res; 2006 Jan; 66(1):69-77. PubMed ID: 16397218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.
    Meyer KB; Maia AT; O'Reilly M; Ghoussaini M; Prathalingam R; Porter-Gill P; Ambs S; Prokunina-Olsson L; Carroll J; Ponder BA
    PLoS Genet; 2011 Jul; 7(7):e1002165. PubMed ID: 21814516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19.
    Hua JT; Ahmed M; Guo H; Zhang Y; Chen S; Soares F; Lu J; Zhou S; Wang M; Li H; Larson NB; McDonnell SK; Patel PS; Liang Y; Yao CQ; van der Kwast T; Lupien M; Feng FY; Zoubeidi A; Tsao MS; Thibodeau SN; Boutros PC; He HH
    Cell; 2018 Jul; 174(3):564-575.e18. PubMed ID: 30033362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer.
    He WW; Sciavolino PJ; Wing J; Augustus M; Hudson P; Meissner PS; Curtis RT; Shell BK; Bostwick DG; Tindall DJ; Gelmann EP; Abate-Shen C; Carter KC
    Genomics; 1997 Jul; 43(1):69-77. PubMed ID: 9226374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare variant of African ancestry activates 8q24 lncRNA hub by modulating cancer associated enhancer.
    Walavalkar K; Saravanan B; Singh AK; Jayani RS; Nair A; Farooq U; Islam Z; Soota D; Mann R; Shivaprasad PV; Freedman ML; Sabarinathan R; Haiman CA; Notani D
    Nat Commun; 2020 Jul; 11(1):3598. PubMed ID: 32680982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of androgen independence at early stages of prostate cancer progression in Nkx3.1; Pten mice.
    Gao H; Ouyang X; Banach-Petrosky WA; Shen MM; Abate-Shen C
    Cancer Res; 2006 Aug; 66(16):7929-33. PubMed ID: 16912166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss.
    Lei Q; Jiao J; Xin L; Chang CJ; Wang S; Gao J; Gleave ME; Witte ON; Liu X; Wu H
    Cancer Cell; 2006 May; 9(5):367-78. PubMed ID: 16697957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis.
    Song H; Zhang B; Watson MA; Humphrey PA; Lim H; Milbrandt J
    Oncogene; 2009 Sep; 28(37):3307-19. PubMed ID: 19597465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.
    Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S
    Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5.
    Kim T; Cui R; Jeon YJ; Lee JH; Lee JH; Sim H; Park JK; Fadda P; Tili E; Nakanishi H; Huh MI; Kim SH; Cho JH; Sung BH; Peng Y; Lee TJ; Luo Z; Sun HL; Wei H; Alder H; Oh JS; Shim KS; Ko SB; Croce CM
    Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4173-8. PubMed ID: 24594601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer.
    Hubbard GK; Mutton LN; Khalili M; McMullin RP; Hicks JL; Bianchi-Frias D; Horn LA; Kulac I; Moubarek MS; Nelson PS; Yegnasubramanian S; De Marzo AM; Bieberich CJ
    Cancer Res; 2016 Jan; 76(2):283-92. PubMed ID: 26554830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4C-seq revealed long-range interactions of a functional enhancer at the 8q24 prostate cancer risk locus.
    Cai M; Kim S; Wang K; Farnham PJ; Coetzee GA; Lu W
    Sci Rep; 2016 Mar; 6():22462. PubMed ID: 26934861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rare variant, which destroys a FoxA1 site at 8q24, is associated with prostate cancer risk.
    Hazelett DJ; Coetzee SG; Coetzee GA
    Cell Cycle; 2013 Jan; 12(2):379-80. PubMed ID: 23255135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.